Verisk responds to a Delaware Supreme Court order regarding the AccuLynx transaction, emphasizing compliance and ongoing commitments.
Quiver AI Summary
Verisk, a prominent data analytics and technology partner for the global insurance industry, has issued a statement regarding the Delaware Supreme Court's ruling on the AccuLynx transaction, affirming the lower court's judgment. The company will comply with the court's order while noting that the transaction is still subject to customary closing conditions and review by the Federal Trade Commission, with no guarantee of completion. Verisk continues to focus on enhancing its services to the insurance sector and delivering long-term value to shareholders.
Potential Positives
- Verisk reaffirmed its commitment to comply with the Delaware Supreme Court’s order regarding the AccuLynx transaction, demonstrating respect for legal processes and regulatory frameworks.
- The company emphasized its ongoing focus on delivering long-term value for shareholders, indicating a strategic approach to corporate governance.
- Verisk highlighted its role as a leader in data analytics and technology for the global insurance industry, showcasing its importance in improving operational efficiency and decision-making amidst evolving market conditions.
- The mention of the company's certification by Great Place to Work suggests a strong workplace culture, which can enhance employee retention and attract top talent.
Potential Negatives
- The press release indicates that the AccuLynx transaction is still subject to customary closing conditions and FTC review, suggesting potential delays or hurdles that could affect the completion of the deal.
- The acknowledgment of the court's judgment may imply legal challenges or complications that could impact the company's operations and reputation.
- The statement includes a caution regarding forward-looking statements, which may cause uncertainty among investors about the company's future performance and strategy.
FAQ
What is the recent Delaware Supreme Court order about?
The order affirms the judgment of the Delaware Chancery Court regarding the AccuLynx transaction.
How will Verisk respond to the court's decision?
Verisk will proceed in accordance with the Court’s order while focusing on its core services in the insurance industry.
What are the conditions for the AccuLynx transaction?
The transaction is subject to customary closing conditions and FTC review, and completion is not guaranteed.
What does Verisk do for the insurance industry?
Verisk provides data analytics and technology to improve efficiency, underwriting, claims, and decision-making on global risks.
Where can I find more information about Verisk?
More information is available on Verisk's website and in the Verisk Newsroom.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$VRSK Insider Trading Activity
$VRSK insiders have traded $VRSK stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $VRSK stock by insiders over the last 6 months:
- LEE SHAVEL (Chief Executive Officer) has made 0 purchases and 4 sales selling 13,105 shares for an estimated $2,533,382.
- SAMUEL G LISS has made 0 purchases and 2 sales selling 11,436 shares for an estimated $2,052,769.
- BRUCE EDWARD HANSEN has made 0 purchases and 2 sales selling 4,671 shares for an estimated $809,252.
- ELIZABETH MANN (Chief Financial Officer) has made 0 purchases and 6 sales selling 2,400 shares for an estimated $432,232.
- KATHY CARD BECKLES (Chief Legal Officer) sold 2,020 shares for an estimated $394,889
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VRSK Revenue
$VRSK had revenues of $806.3M in Q2 2026. This is an increase of 4.36% from the same period in the prior year.
You can track VRSK financials on Quiver Quantitative's VRSK stock page.
You can access data on VRSK stock through the Quiver Quantitative API.
$VRSK Congressional Stock Trading
Members of Congress have traded $VRSK stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VRSK stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/16, 05/15 and 1 sale worth up to $15,000 on 08/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$VRSK Hedge Fund Activity
We have seen 442 institutional investors add shares of $VRSK stock to their portfolio, and 523 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. removed 2,899,158 shares (-94.2%) from their portfolio in Q2 2026, for an estimated $520,485,835
- BAMCO INC /NY/ added 2,190,629 shares (+87.2%) to their portfolio in Q2 2026, for an estimated $393,283,624
- PARNASSUS INVESTMENTS, LLC removed 1,760,761 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $316,109,422
- BLACKROCK, INC. removed 1,558,084 shares (-13.1%) from their portfolio in Q2 2026, for an estimated $279,722,820
- ALLIANCEBERNSTEIN L.P. removed 1,232,174 shares (-17.0%) from their portfolio in Q2 2026, for an estimated $221,212,198
- MILLENNIUM MANAGEMENT LLC added 981,433 shares (+2317.5%) to their portfolio in Q2 2026, for an estimated $176,196,666
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 851,907 shares (+inf%) to their portfolio in Q2 2026, for an estimated $152,942,863
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VRSK Price Targets
Multiple analysts have issued price targets for $VRSK recently. We have seen 2 analysts offer price targets for $VRSK in the last 6 months, with a median target of $210.0.
Here are some recent targets:
- Joshua Dennerlein from B of A Securities set a target price of $190.0 on 05/19/2026
- Andrew Steinerman from JP Morgan set a target price of $230.0 on 04/30/2026
Full Release
JERSEY CITY, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today issued the following statement in response to the Delaware Supreme Court order regarding the AccuLynx transaction:
“We respect the Delaware Supreme Court’s order to affirm the judgment of the Delaware Chancery Court. We will proceed in accordance with the Court’s order. The transaction remains subject to the satisfaction of customary closing conditions and FTC review, and there is no guarantee that the transaction will be completed. We remain focused on serving as a strategic data and technology partner to the global insurance industry and continuing to deliver long-term value for our shareholders.”
###
About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by
Great Place to Work
. For more,
visit Verisk.com
and the
Verisk Newsroom
.
Forward-Looking Statements
This release contains forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “will,” “expect,” “intend,” “plan,” “target,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements, because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of activity, performance or achievements.
